Philip Ward is ACT's European editor, phone +44 1244 538583, firstname.lastname@example.org
DIA EuroMeeting Gets Set for 25th Anniversary
The Drug Information Association (DIA) is preparing to celebrate 25 years of training and education provision at its annual EuroMeeting.
Can Usain Bolt et al lure EMA staff from their desks?
Fresh Doubts Cast Over Post-Marketing Trials
Criticisms of the pharmaceutical industry's real motives for undertaking post-marketing studies have been made by a special report in the British Medical Journal.
Remembering Dr. Edmund de Maar
Europe Gets Serious About Geriatric Trials
New Patient Group Targets DIA EuroMeeting
The European Patients' Academy on Therapeutic Innovation faces its first major test during the 2012 Drug Information Association EuroMeeting.
Research Fraud Requires Urgent Action
A British Medical Journal survey suggests that misconduct in research is not going away.
Imaging Pharmacovigilance Needs Overhaul
The importance of safe use of imaging agents was highlighted at the Chicago Radiological Society of North America conference.
Ethics of Biobank Research Come Under Scrutiny
Biobank research has a valuable role to play in R&D, but handling the consent process is rarely straightforward.
Debate Grows Over Comparative Efficacy Trials
UK officials stress importance of evaluating benefits of new therapies before approval.
EMA Commits to London for a Quarter Century
The EMA is moving its offices to Canary Wharf Estate.
EFGCP Advocates Change to Consent Process
The EFGCP annual conference in January aims to improve information and empower patients.
Italian Regulator Prepares for Europe's Top Job
Guido Rasi, MD, prepares to take on his new role.
EMA Seeks to Fine-Tune Official Register
The new online register will help patients access trials information more easily.
Economic Squeeze Poses Threat to R&D
Europe's financial problems have resulted in new blackslists of drugs among other challenges.
Pfizer Closure Deals Serious Blow to Europe
The recent shutdown of the R&D facility should signify a warning to the British science community.
State Cash Fuels Growth in England
Patient participation increased drastically in England in 2010.
EFGCP to Establish Changes in GCP Training
GCP training will be the main point of discussion at the EFGCP meeting in February.
Pressure Grows to Publish Data
Some believe that the medical evidence base is distorted by missing clinical trial data.
Hope Rises for Safety Law
Pharmacists and patient groups welcome the new European Union directive on pharmacovigilance.
Geriatric Trials Spark Debate
A new report from EFGCP and EUCROF suggests changes to geriatric trials.
EMA Reveals Online Plans
The European Medicines Agency has redesigned its Web site to improve transparency.
Europe Gives Seniors a Voice
A major European congress looks set to focus attention on the growing campaign for more participation of the elderly in clinical trials.
The Spotlight Falls on India
Indian CROs face new guidelines as the country's clinical trial market continues to face infrastructure issues.
Russia Continues to Lure Sponsors
The current state of the clinical trial market in Russia.
Pressure Mounts to Involve Elderly
The European intiative of involving elderly in clinical trials picks up the pace as challenges are addressed.
Industry Reacts to Bad Review
Industry professionals address critical commentary of the drug development process.
Dutch Researchers Finally Climb on Board
The Netherlands has become the latest European country to establish a network that is designed to promote pediatric drug development.
IFAPP's New President Seeks Stronger Links with Emerging World
EDC Progress Steady for Europe and Asia
EDC is being embraced by both continents, where its efficiency is welcomed despite a few kinks.
2 Commerce Drive Cranbury, NJ 08512